Chemicals
Bayer’s Ruveon Overhaul and Analyst Divergence Signal a Pivotal Moment After a 40% Rally
Bayer has moved decisively to reshape its US glyphosate operations, folding the business into a newly created entity called Ruveon...
Bayer’s Legal ‘Watershed’ and Operational Overhaul Drive a 43% Rally — Now the Hard Part Begins
A double dose of good news has reignited Bayer’s stock. The U.S. Supreme Court handed the German conglomerate a landmark...
From Toxic Giant Hogweed to Stolen Road Rollers: Germany’s Construction Safety Risks on Full Display as Summer Projects Begin
As Germany’s summer holidays start on July 6, a wave of major construction projects is rolling out across Saxony and...
Bayer’s Supreme Court Victory Reshapes the Legal Landscape — But the July 9 Hearing Will Test Whether the Rally Can Hold
The U.S. Supreme Court handed Bayer a landmark win on June 25, effectively closing the most potent legal avenue for...
Bayer’s Two-Front Offensive: Legal Closure Paves the Way for a Pipeline-Fueled Rebound
The Supreme Court’s 7–2 ruling excising thousands of Roundup claims from Bayer’s docket was the kind of event that sends...
Mutares Heads Into Late-June Gauntlet With a No-Cash Deal and a Dividend Question
The coming week will test whether Mutares can simultaneously clear a covenant hurdle, integrate a loss-making Czech chemicals plant, and...
BASF Completes Initial Buyback Phase as €12 Billion Capital Return Program Gathers Pace
The first chapter of BASF’s ambitious shareholder payout story is closing. By the end of June, the chemicals giant will...
Judgment Day for Bayer: Supreme Court Ruling Looms Over New CFO and Pipeline Progress
Bayer shares vaulted 4.6% to €37.51 on Thursday, hitting a monthly high as investors placed their bets on a single...
Germany Adds Pesticide-Triggered Parkinson’s to Occupational Disease List, as Only 30% of Claims Win Approval
The path to compensation for occupational illnesses in Germany remains a steep climb. Of the 90,749 suspected cases reported last...
Bayer’s Technical Battle at the 200-Day Line Gets Reinforcement from Agriculture AI and Kidney Drug Progress
Bayer shares entered the week walking a tightrope just above a key long-term trendline, but the company’s pipeline and digital...
Don't Miss It
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
